Mannkind (MNKD) EPS (Weighted Average and Diluted) Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -82.39% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -97.49% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.45% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,178.57% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -225.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -225.00% |
| Dec 31, 2025 | -266.67% |
| Sep 30, 2025 | -25.00% |
| Jun 30, 2025 | 121.38% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 200.00% |
| Sep 30, 2024 | 300.00% |
| Jun 30, 2024 | 50.00% |
| Mar 31, 2024 | 200.00% |
| Dec 31, 2023 | 114.29% |
| Sep 30, 2023 | 116.67% |
| Jun 30, 2023 | 81.82% |
| Mar 31, 2023 | 60.00% |
| Dec 31, 2022 | 36.36% |
| Sep 30, 2022 | -200.00% |
| Jun 30, 2022 | 21.43% |
| Dec 31, 2021 | 7.29% |
| Dec 31, 2018 | 78.57% |
| Sep 30, 2018 | 48.39% |
| Jun 30, 2018 | 54.29% |
| Mar 31, 2018 | -47.06% |
| Dec 31, 2017 | -150.00% |
| Sep 30, 2017 | -123.66% |
| Jun 30, 2017 | -6.06% |
| Mar 31, 2017 | 41.38% |
| Dec 31, 2016 | 112.99% |
| Sep 30, 2016 | 1,737.50% |